- - First Randomized Controlled Trial to Show That Basal Plus ...
- Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today ...
- Nearly one in five people with diabetes are regularly unable to attend a full day at work due to ...
- - NOT INTENDED FOR US MEDIA - Ingenol Mebutate is an ...
- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...
- Results of a new analysis from the largest-ever morbi-mortality study of ...
The trial against Indonesia Interfaith Spiritual Activist Anand Krishna, who allegedly violating Article 290 and 294 ...
Indonesia has called on the international community to cut global demand for narcotics and drugs as part of a ...
-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended ...
- - The Additional Funds Will Enable the Company to Expand its Therapeutic ...
Jakarta (ANTARA News) - Indonesia ihas begun exporting aglewood directly to China after having always done so ...
- Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new ...